Cancer BiologybioRxivPreprint
Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer
H. C. Donker, B. van Es, M. Tamminga…·H. J. M. Groen
This study identifies mutational signatures linked to immunotherapy response in NSCLC and develops a model to predict durable benefit.
DOI 10.1101/2022.09.23.509152